Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$614K Buy
5,738
+1,257
+28% +$138K 0.02% 563
2026
Q1
$471K Buy
4,481
+1,979
+79% +$232K 0.02% 594
2025
Q4
$312K Buy
2,502
+737
+42% +$87.8K 0.02% 739
2025
Q3
$212K Buy
1,765
+217
+14% +$22.9K 0.01% 940
2025
Q2
$142K Sell
1,548
-371
-19% -$33.8K 0.01% 1156
2025
Q1
$169K Buy
1,919
+413
+27% +$40.6K 0.01% 867
2024
Q4
$139K Buy
1,506
+215
+17% +$20.7K 0.01% 897
2024
Q3
$120K Buy
1,291
+665
+106% +$55.8K 0.01% 884
2024
Q2
$46.9K Sell
626
-102
-14% -$8.14K 0.01% 1237
2024
Q1
$62.8K Buy
728
+214
+42% +$16.4K 0.01% 887
2023
Q4
$36.9K Buy
+514
New +$31K 0.01% 1092

Other funds holding CRH

GAMMA Investing's CRH Position: Q2 2026 in Review

GAMMA Investing increased its CRH (CRH) stake by 28% in Q2 2026, buying an estimated $138K and bringing the position to 5,738 shares worth $614K. The position accounts for 0.02% of the portfolio, ranked #563.

GAMMA Investing first reported a position in CRH in Q4 2023 and has held it in 11 quarters since. 235 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • GAMMA Investing held 5,738 shares of CRH worth $614K as of Q2 2026.
  • GAMMA Investing bought 1,257 CRH shares in Q2 2026, an estimated $138K.
  • CRH made up 0.02% of GAMMA Investing's portfolio in Q2 2026, its #563 holding.
  • GAMMA Investing first reported a position in CRH in Q4 2023 and has held it in 11 quarters since.
  • 235 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.